Figure 1.
Effects of rosuvastatin on the primary composite endpoint according to baseline characteristics. The dashed overall line indicates the overall hazard ratio for the entire cohort (men and women combined).
Effects of rosuvastatin on the primary composite endpoint according to baseline characteristics. The dashed overall line indicates the overall hazard ratio for the entire cohort (men and women combined).